Navigation Links
Cohera Medical Commercializes TissuGlu® Surgical Adhesive in Germany
Date:11/17/2011

PITTSBURGH, Nov. 17, 2011 /PRNewswire/ -- Cohera Medical, a rapidly growing medical device company, announced today that it has begun selling its lead product, TissuGlu® Surgical Adhesive, to hospitals and surgeons in three pilot territories in Germany.  This regional launch will document and highlight the advantages of TissuGlu and will be used to drive a wider expansion throughout Germany and to additional European markets in early 2012.

In a limited pre-launch phase started in September 2011, a select group of leading plastic and reconstructive surgeons performed over 80 plastic surgery procedures with TissuGlu.

"I am very excited for the benefits that TissuGlu will bring not only to the patients in my practice, but to plastic and reconstructive surgeons worldwide performing large-flap plastic surgery procedures," said Professor Axel-Mario Feller, an internationally renowned leader in reconstructive breast surgery based in Munich, Germany. "By reducing fluid accumulation and shortening time to drain removal, patient satisfaction and outcomes will be improved and costs of care will be reduced."

During the pre-launch, the clinical experience from using TissuGlu was shared during the OGPARC/DGPRAC/VDAPC Congress in Innsbruck, Austria, an international meeting held in late-September, attended by over 800 plastic and reconstructive surgeons. Cohera Medical also sponsored a scientific symposium that generated significant visibility and interest in the product. The resulting discussion also highlighted the potential for TissuGlu to play an important role in surgeries beyond the aesthetic field.

"The reaction to TissuGlu among the top plastic surgeons in Germany has been great.  Initial uptake by many of the most respected plastic surgeons have exceeded our initial forecast during this portion of our launch," said Patrick Daly, President and CEO of Cohera Medical. "Our focus continues to be on excellent patient outcomes and e
'/>"/>

SOURCE Cohera Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. First Patient Treated in Clinical Study of Cohera Medicals TissuGlu(R) Surgical Adhesive
2. Frost & Sullivan Recognizes Cohera Medical, Inc.® for Developing TissuGlu®, Its Pioneering Surgical Adhesive That Is Strong, Easy-To-Use, Biocompatible and Resorbable
3. Cohera Medical Receives CE Mark Approval for TissuGlu® Surgical Adhesive
4. Cohera Medical and CEO Receive Pittsburgh Tech 50 Awards
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Globus Medical Raises $110 Million in Series E Financing Round
9. Quark Pharmaceuticals Appoints New Chief Medical Officer
10. Boston University Biomedical Engineers Find Chink in Bacterias Armor
11. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... LOS ANGELES , May 4, 2015 /PRNewswire/ ... research and development company specializing in oncology, today ... phase 1b aldoxorubicin combination studies pairing aldoxorubicin with ... doses of gemcitabine or ifosfamide with escalating doses ... tolerated, and even at the lowest dose level ...
(Date:5/4/2015)... , May 4, 2015 Dyadic ... company whose patented and proprietary technologies are used ... proteins for the bioenergy, bio-based chemical, biopharmaceutical and ... report its financial results for quarter ending March ... 14, 2015 and will host a conference call ...
(Date:5/4/2015)... , May 4, 2015  Verus Healthcare, Inc. ... acquisition of CPAP Care Club in 2012.  Since that ... within the durable medical equipment (DME) industry by 1,000%.  ... for their CPAP supply needs and processes nearly 14,000 ... this company three years ago, the systems and processes ...
Breaking Medicine Technology:CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 2CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 3CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 4CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 5CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 6CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 7Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 2Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 3Verus Healthcare Celebrates 1,000% Growth on Third Anniversary 2
(Date:5/4/2015)... 04, 2015 Ticket Down is a reputable ... Cup (ICC) . While the World Cup is the ... every four years, the International Champions Cup is one of ... the all-time attendance record for soccer in the United States ... House at the University of Michigan. This year, the defending ...
(Date:5/4/2015)... Angeles, CA (PRWEB) May 04, 2015 ... Sands, is now offering a more comfortable and attractive ... the restoration of choice for those who have lost ... Dentures can feel insecure or slip at the worst ... patient eats or talks. They can also painfully pinch ...
(Date:5/4/2015)... 2015 New findings released today from ... (ABTA) show that people diagnosed with a brain tumor ... including clinical trials, at the time of diagnosis, and ... decisions about their course of treatment. The release of ... nationwide brain tumor volunteer network, the ABTA CommYOUnity™, dedicated ...
(Date:5/4/2015)... San Diego, CA (PRWEB) May 04, 2015 ... hosted a ribbon cutting ceremony at their brand new, ... of this year. The new building will not only ... patient population, but will also offer community and educational ... , The new facility is located next door to ...
(Date:5/4/2015)... Helena, MT (PRWEB) May 04, 2015 ... partnered with Care to Care, LLC to manage outpatient ... will help New West Medicare ensure its members are ... avoid unnecessary radiation. , Working closely with New West ... in promoting the safe use of advanced imaging and ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2
... researchers say , , WEDNESDAY, Jan. 30 (HealthDay News) -- ... a Canadian study that found that DBS of the ... , DBS -- which involves electrical stimulation of ... disease and other movement disorders, and is being studied ...
... known to doctors as a hormone that boosts red-blood-cell production. ... PhD, an ophthalmologist at Children,s Hospital Boston, shows it also ... The findings not only add a new function to the ... prescribing it to patients with diseases affected by abnormal blood-vessel ...
... Caraco Pharmaceutical,Laboratories, Ltd. (Amex: CPD ) ... Tablets, 40 mg (Pantoprazole Sodium,DR), which is AB-rated ... Sun,Pharmaceutical Industries, Ltd. (Sun Pharma). Sun Pharma recently ... (FDA) for its Abbreviated,New Drug Application (ANDA) for ...
... CALL DATE: Wednesday, Feb. 27, 2008 ... 8:30 a.m. Eastern Time ... Chairman and CEO Kendle (Nasdaq: KNDL ) will conduct a telephone conference ... for the Fourth Quarter and Year Ended Dec. 31, 2007. A,question and answer session ...
... Stryker Corporation,(NYSE: SYK ) announced today that it ... at 8:00 a.m. Eastern Time, in New York, New ... Officer, will host,the meeting with presentations by leaders of ... the meeting will be available on Stryker,s,website at ...
... Crowell & Moring LLP is,pleased to announce the ... office as a member of the firm,s Antitrust and ... she helped found and co-chair,the firm,s Healthcare Industry Group. ... Trade Commission (FTC), where she investigated and,prosecuted mergers, joint ...
Cached Medicine News:Health News:Deep Brain Stimulation May Improve Recall 2Health News:Anemia treatment may be a double-edged sword 2Health News:Anemia treatment may be a double-edged sword 3Health News:Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R) 2Health News:Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R) 3Health News:Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast 2Health News:Stryker to Host Analyst Meeting 2Health News:Former FTC Attorney Christine White Joins Crowell & Moring's Health Care and Antitrust Groups 2Health News:Former FTC Attorney Christine White Joins Crowell & Moring's Health Care and Antitrust Groups 3
Liquichek Pediatric Control is a product designed to monitor important analytes for neonatal testing. This control monitors four bilirubin parameters at two clinically significant levels....
... Chemistry Control (Human) provides a comprehensive ... enzymes and CO2. It requires no ... most major instruments and methodologies. Available ... fill sizes (10 mL fill size ...
Liquid Assayed and Unassayed Multiqual Controls are comprehensive, liquid, human serum based chemistry controls, available in three levels....
Lyphochek® Drug Free Serum can serve as a drug-free baseline for HPLC analysis or as a negative control....
Medicine Products: